| NCT06421987
| Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors | No drug interventions | Not Available | Not Available | recruiting |
| NCT04268706
| Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) | | treatment | 2 | active_not_recruiting |
| NCT04653649
| CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma. | No drug interventions | treatment | 1 / 2 | unknown_status |
| NCT03155425
| PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma | | treatment | 2 | completed |
| NCT03535948
| Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy | No drug interventions | Not Available | Not Available | unknown_status |
| NCT04292626
| Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose | No drug interventions | diagnostic | 1 | completed |
| NCT04776265
| RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT | No drug interventions | Not Available | Not Available | recruiting |
| NCT01578967
| Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma | No drug interventions | treatment | Not Available | completed |
| NCT04636255
| Physical Capacity in Hodgkin Lymphoma Survivors | No drug interventions | prevention | Not Available | unknown_status |
| NCT04758650
| Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis | No drug interventions | diagnostic | 2 | recruiting |
| NCT04638790
| First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) | No drug interventions | treatment | 3 | recruiting |
| NCT04378647
| BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant | No drug interventions | treatment | 2 | recruiting |
| NCT05798897
| Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma | No drug interventions | treatment | 1 | recruiting |
| NCT03914885
| Compassionate Use Re-Infusion of ATLCAR.CD30 | No drug interventions | Not Available | Not Available | no_longer_available |
| NCT05137886
| PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma | No drug interventions | treatment | 2 | recruiting |
| NCT03260101
| Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study | No drug interventions | Not Available | Not Available | unknown_status |
| NCT03417765
| Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas | No drug interventions | supportive_care | 1 / 2 | withdrawn |
| NCT01484015
| Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia | | treatment | 1 | completed |
| NCT02396134
| Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant | No drug interventions | supportive_care | 2 | active_not_recruiting |
| NCT02728700
| Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT | No drug interventions | prevention | 1 | terminated |